Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

4.29
Delayed Data
As of 4:00pm ET
 -0.01 / -0.23%
Today’s Change
2.88
Today|||52-Week Range
5.35
+9.44%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$72.1M

Company Description

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ.

Contact Information

Brainstorm Cell Therapeutics, Inc.
1745 Broadway
New York New Jersey 10019
P:(201) 488-0460
Investor Relations:

Employees

Shareholders

Mutual fund holders4.51%
Other institutional4.30%
Individual stakeholders13.61%

Top Executives

Chaim LebovitsPresident & Chief Executive Officer
Ralph Z. KernChief Operating & Medical Officer
Eyal RubinChief Financial Officer, Treasurer & Executive VP
Yael GothelfVice President-Scientific & Regulatory Affairs
Revital Geffen-ArichaVice President-Research & Development